Chronic Kidney Disease Trial, Recruiting NCT07444203 Sponsor: University of Pennsylvania Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07444203
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People whose kidneys are functioning at a level of at least 10 ml/min/1.73 m² (a measure of kidney function that the trial site can confirm from blood test results)
  • People who have already had a kidney biopsy, a kidney donor biopsy, or a kidney removal procedure for clinical reasons, with tissue available from that procedure
  • People who are willing and able to agree to having their pathology results and medical records used for this research

Who may not be able to join:

  • People who are unable to give their own consent to participate in the research
  • People whose stored kidney tissue from a previous procedure is no longer available to be used to make slides for analysis
  • People whose hospital or medical institution has a policy that prevents kidney tissue slides from being shared for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katalin Susztak, MD, PhD, University of Pennsylvania

Phone: 2673030158

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 November 2025
Est. completion
30 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Kidney Tissue molecular fingerprint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov